Mitochondria

The CHOP-Penn Autism Research Symposium explored opportunities for breakthroughs in the understanding and treatment of autism spectrum disorder.

Shahreen Amin, MD, PhD, discusses her definition of diversity in science and her research on lysosomal storage diseases.

The Connor Initiative, a multimillion dollar gift from the Holveck Family, will support precision therapeutics for osteosarcoma and rare cancers.

Douglas C. Wallace, PhD, investigates the role of adaptive immunity in the etiology of Alzheimer’s disease (AD) and AD-related dementias.

In our weekly news roundup, Dr. Beverly Davidson received a $1 million grant to study Huntington’s disease. This and more on Cornerstone.

This week’s In The News reports on higher education vaccination policies, college athletes’ concussions, a new genetic disease, and zebrafish.

The FDA approved an oral drug, based on foundational research conducted at CHOP, to treat a rare, severe bone disease. More In The News.

With a grant from the Gates Foundation, CHOP researchers are working to determine the importance of mitochondria DNA variation in COVID-19 severity.

Featured Diversity Fellow Arnold Olali, PhD, is focused on understanding how mitochondria affect overall health.

Learn about earn about a regional research collaboration, prestigious awards, and listen to a special podcast series.